Skip to content

Ingersoll Rand IR Free cash flow

Free cash flow at other companies

Dover logo
DoverDOV
$131.19M+20.0%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$816M+126%
GHM
Graham CorporationGHM
-$2.72M
Flowserve logo
FlowserveFLS
Graco logo
GracoGGG
IDEX logo
IDEXIEX

Other financials

Income statement

See full
Revenue$1.8B+7.6%
Gross profit$792.4M+3.5%
Operating income$289.7M-4.2%
Net income$192.1M+3.0%
EPS (diluted)$0.49+6.5%

Balance sheet

See full
Cash & equivalents$1.3B-21.0%
Total debt$4.8B+0.2%
Total equity$10.2B-3.0%
Total assets$18.2B-0.9%

Cash flow

See full
Operating cash flow$199.7M-22.1%
CapEx$36.3M+7.7%

Valuation

See full
Market cap$32.09B-10.2%
Enterprise value$35.65B-9.1%
P/E54.7×-13.7×
P/S4.1×-0.7×

Profitability

See full
Gross margin43.2%-0.6pp
Operating margin14.5%-3.4pp
Net margin7.5%-3.8pp
FCF margin14.9%-3.9pp

Returns & leverage

See full
Return on equity5.7%-2.4pp
Debt / equity0.5×0.0×
Current ratio2.2×-0.2×

Where this comes from

Calculated from Ingersoll Rand’s reported figures.

The official record: Ingersoll Rand’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ingersoll Rand's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ingersoll Rand's free cash flow?
Ingersoll Rand (IR) reported free cash flow of $163.4M in Q1 2026.
How has Ingersoll Rand's free cash flow changed year-over-year?
Ingersoll Rand's free cash flow decreased by 26.6% year-over-year, from $222.7M to $163.4M.
What is the long-term trend for Ingersoll Rand's free cash flow?
Over 4 years (2021 to 2025), Ingersoll Rand's free cash flow has grown at a 21.3% compound annual growth rate (CAGR), from $563.7M to $1.22B.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.